ManagemEnt of Antifungal Drug in Invasive Aspergillosis：a Real-word Study
NCT ID: NCT06028451
Last Updated: 2023-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
550 participants
OBSERVATIONAL
2023-09-25
2024-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
NCT06819410
Systemic Fungal Infections in ICU Patients
NCT03292224
Clinical Trial of Pulmonary Cryptococcosis in China
NCT02503449
Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease
NCT01499433
Isavuconazole in Critically Ill Patients: Efficacy and Safety
NCT07080359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survivors
Critically ill patients with invasive aspergillus infection who survived
Record the information data
Record the information data
Nonsurvivors
Critically ill patients with invasive aspergillus infection who not survived
Record the information data
Record the information data
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Record the information data
Record the information data
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagosed as invasive aspergillus infection
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southeast University, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jingyuan,Xu
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jingyuan Xu, M.D.
Role: PRINCIPAL_INVESTIGATOR
Southeast University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southeast University, Zhongda hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023ZDSYLL357-P01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.